HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children
出版年份 2013 全文链接
标题
HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 94, Issue 1, Pages 142-149
出版商
Springer Nature
发表日期
2013-04-15
DOI
10.1038/clpt.2013.55
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population
- (2011) Cecilie Johannessen Landmark et al. EPILEPSY RESEARCH
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
- (2011) Yan Zhang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2011) Maja Mockenhaupt Expert Review of Clinical Immunology
- Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
- (2011) Tai-Ming Ko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children
- (2011) Y. Finkelstein et al. PEDIATRICS
- Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
- (2011) Qian Wang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
- (2010) B Sassolas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2010) Nahoko Kaniwa et al. EPILEPSIA
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
- (2010) X.T. Wu et al. EPILEPSY & BEHAVIOR
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
- (2010) Takeshi Ozeki et al. HUMAN MOLECULAR GENETICS
- Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations
- (2010) F. F. Gonzalez-Galarza et al. NUCLEIC ACIDS RESEARCH
- Identifying genomic and developmental causes of adverse drug reactions in children
- (2010) Mara L Becker et al. PHARMACOGENOMICS
- HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
- (2009) Hiroko Ikeda et al. EPILEPSIA
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians
- (2009) TimirY Mehta et al. Indian Journal of Dermatology Venereology & Leprology
- Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis
- (2009) N. Levi et al. PEDIATRICS
- Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals
- (2009) BC Carleton et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Application of principal component analysis to pharmacogenomic studies in Canada
- (2009) H Visscher et al. PHARMACOGENOMICS JOURNAL
- Antiepileptic drug utilization in children from 1997–2005—a study from the Netherlands
- (2008) N. W. van de Vrie-Hoekstra et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started